ToxPoint article highlights alternative mechanism to bring focus to major issues in toxicology

The new year has brought with it advances to the Society of Toxicology's official journal, Toxicological Sciences, some of which are reflected in the January 2020 issue-;Volume 173, Issue 1.

In addition to articles exploring such areas as biomarkers, nano- and neurotoxicology, and developmental and reproductive toxicology, the January issue has introduced a new category, ToxPoint, which ToxSci Editor-in-Chief Jeffrey M. Peters describes in his January editorial as "an alternative mechanism to bring attention to important issues in the field of toxicology."

The ToxPoint article published in Volume 173, Issue 1, "In the Era of Precision Medicine, Diversity Should Not Be Neglected in Chemical Safety Assessment," was authored by ToxSci Deputy Editor Alison H. Harrill.

Also included in the January edition of the journal are four Tox Spotlight articles:

  • "Development of a Generic Physiologically Based Kinetic Model to Predict In Vivo Uterotrophic Responses Induced by Estrogenic Chemicals in Rats Based on In Vitro Bioassays"
  • "Tissue-Engineered Bone Tumor as a Reproducible Human In Vitro Model for Studies of Anticancer Drugs"
  • "Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans"
  • "Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization"
Source:
Journal reference:

Peters, J. M. (2020) Change is Good: What is New for ToxSci?. Toxicological Sciences. doi.org/10.1093/toxsci/kfz230.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How carrageenan affects insulin resistance